|
1
|
Chen YJ: Potential role of tetrandrine in
cancer therapy. Acta Pharmacol Sin. 23:1102–1106. 2002.PubMed/NCBI
|
|
2
|
Zhu X, Sui M and Fan W: In vitro and in
vivo characterizations of tetrandrine on the reversal of
P-glycoprotein-mediated drug resistance to paclitaxel. Anticancer
Res. 25:1953–1962. 2005.PubMed/NCBI
|
|
3
|
Holohan C, Van Schaeybroeck S, Longley DB
and Johnston PG: Cancer drug resistance: An evolving paradigm. Nat
Rev Cancer. 13:714–726. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tang F, Ouyang H, Yang JZ and Borchardt
RT: Bidirectional transport of rhodamine 123 and Hoechst 33342,
fluorescence probes of the binding sites on P-glycoprotein, across
MDCK-MDR1 cell monolayers. J Pharm Sci. 93:1185–1194. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oga EF, Sekine S, Shitara Y and Horie T:
Potential P-glycoprotein-mediated drug-drug interactions of
antimalarial agents in Caco-2 cells. Am J Trop Med Hyg. 87:64–69.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong X and Mumper RJ: Nanomedicinal
strategies to treat multidrug-resistant tumors: Current progress.
Nanomedicine (Lond). 5:597–615. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu KJ, He JH, Su XD, Sim HM, Xie JD, Chen
XG, Wang F, Liang YJ, Singh S, Sodani K, et al: Saracatinib
(AZD0530) is a potent modulator of ABCB1-mediated multidrug
resistance in vitro and in vivo. Int J Cancer. 132:224–235. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hidalgo IJ, Raub TJ and Borchardt RT:
Characterization of the human colon carcinoma cell line (Caco-2) as
a model system for intestinal epithelial permeability.
Gastroenterology. 96:736–749. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Artursson P: Epithelial transport of drugs
in cell culture. I: A model for studying the passive diffusion of
drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci.
79:476–482. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wacher VJ, Silverman JA, Zhang Y and Benet
LZ: Role of P-glycoprotein and cytochrome P450 3A in limiting oral
absorption of peptides and peptidomimetics. J Pharm Sci.
87:1322–1330. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Palm K, Luthman K, Ros J, Grasjo J and
Artursson P: Effect of molecular charge on intestinal epithelial
drug transport: pH-dependent transport of cationic drugs. J
Pharmacol Exp Ther. 291:435–443. 1999.PubMed/NCBI
|
|
12
|
Raeissi SD, Hidalgo IJ, Segura-Aguilar J
and Artursson P: Interplay between CYP3A-mediated metabolism and
polarized efflux of terfenadine and its metabolites in intestinal
epithelial Caco-2 (TC7) cell monolayers. Pharm Res. 16:625–632.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
van Breemen RB and Li Y: Caco-2 cell
permeability assays to measure drug absorption. Expert Opin Drug
Metab Toxicol. 1:175–185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Artursson P and Karlsson J: Correlation
between oral drug absorption in humans and apparent drug
permeability coefficients in human intestinal epithelial (Caco-2)
cells. Biochem Biophys Res Commun. 175:880–885. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yee S: In vitro permeability across Caco-2
cells (colonic) can predict in vivo (small intestinal) absorption
in man-fact or myth. Pharm Res. 14:763–766. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Irvine JD, Takahashi L, Lockhart K, Cheong
J, Tolan JW, Selick HE and Grove JR: MDCK (Madin-Darby canine
kidney) cells: A tool for membrane permeability screening. J Pharm
Sci. 88:28–33. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Canitrot Y and Lautier D: Use of rhodamine
123 for the detection of multidrug resistance. Bull Cancer.
82:687–697. 1995.(In French). PubMed/NCBI
|
|
18
|
Ludescher C, Gattringer, Drach J, Hofmann
J and Grunicke H: Rapid functional assay for the detection of
multidrug-resistant cells using the fluorescent dye rhodamine 123.
Blood. 78:1385–1387. 1991.PubMed/NCBI
|
|
19
|
Twentyman PR, Rhodes T and Rayner S: A
comparison of rhodamine 123 accumulation and efflux in cells with
P-glycoprotein-mediated and MRP-associated multidrug resistance
phenotypes. Eur J Cancer. 30A:1–1369. 1994.PubMed/NCBI
|
|
20
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: Application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cao Z, Li X, Liao X and Yang P:
Development of an HPLC-FLD method for determination of rhodamine
123 in Caco-2 cell-based permeability studies. Chromatographia.
79:261–266. 2016. View Article : Google Scholar
|
|
22
|
Mi Y and Lou L: ZD6474 reverses multidrug
resistance by directly inhibiting the function of P-glycoprotein.
Br J Cancer. 97:934–940. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iqbal J, Hombach J, Matuszczak B and
Bernkop-Schnurch A: Design and in vitro evaluation of a novel
polymeric P-glycoprotein (P-gp) inhibitor. J Control Release.
147:62–69. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun YF and Wink M: Tetrandrine and
fangchinoline, bisbenzylisoquinoline alkaloids from Stephania
tetrandra can reverse multidrug resistance by inhibiting
P-glycoprotein activity in multidrug resistant human cancer cells.
Phytomedicine. 21:1110–1119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Choi CH: ABC transporters as multidrug
resistance mechanisms and the development of chemosensitizers for
their reversal. Cancer Cell Int. 5:302005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Foger F, Schmitz T and Bernkop-Schnurch A:
In vivo evaluation of an oral delivery system for P-gp substrates
based on thiolated chitosan. Biomaterials. 27:4250–4255. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Artursson P: Cell cultures as models for
drug absorption across the intestinal mucosa. Crit Rev Ther Drug
Carrier Syst. 8:305–330. 1991.PubMed/NCBI
|
|
28
|
Rubas W, Cromwell ME, Shahrokh Z,
Villagran J, Nguyen TN, Wellton M, Nguyen TH and Mrsny RJ: Flux
measurements across Caco-2 monolayers may predict transport in
human large intestinal tissue. J Pharm Sci. 85:165–169. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Korjamo T, Honkakoski P, Toppinen MR, Niva
S, Reinisalo M, Palmgrén JJ and Mönkkönen J: Absorption properties
and P-glycoprotein activity of modified Caco-2 cell lines. Eur J
Pharm Sci. 26:266–279. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Doppenschmitt S, Spahn-Langguth H, Regardh
CG and Langguth P: Role of P-glycoprotein-mediated secretion in
absorptive drug permeability: An approach using passive membrane
permeability and affinity to P-glycoprotein. J Pharm Sci.
88:1067–1072. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tajima T, Nakajima A and Fuchigami T:
Electrolytic partial fluorination of organic compounds. 83. Anodic
fluorination of N-substituted pyrroles and its synthetic
applications to gem-difluorinated heterocyclic compounds. J Org
Chem. 71:1436–1441. 2006. View Article : Google Scholar : PubMed/NCBI
|
